Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
Morrison Foerster covers the pharmaceuticals, biologics, diagnostics, personalised medicine, medical devices, medicinal chemicals, and vaccines sectors. The firm is also lauded for its specialisms in IP protection, licensing, pharmacovigilance, and clinical and commercial supply agreements. Other key areas are US-China investigations, drug and device safety, cybersecurity, corruption, compliance, and cross-border transactions. The practice is co-led by managing partner of the Beijing and Shanghai offices, Chuan Sun, who acts for major life sciences clients, including healthcare private equity firms; and Hong Kong-based Gordon Milner, an expert in pharmaceutical and biotechnology industry-related technology projects. Beijing-based Sarah Wang advises on corporate commercial and technology transactions in the life sciences sector; while Chen Zhu and Tyler Xiu are other names in Hong Kong to note.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘MOFO provides very comprehensive legal services to clients.’
‘Chuan Sun is a very experienced healthcare industry lawyer - outstanding.’
Clients clés
- Ally Bridge Group
- Celadon Partners
Points forts
- Advised Jamieson Laboratories and its parent company Jamieson Wellness on their partnership with international private equity firm DCP Capital.
- Advising Celadon Partners on its launch of GeneFab, a contract research, development, and manufacturing organisation (business partnering with the cell and gene therapy industry).